• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用分区分析作为一种简单的方法来推导净清除率。

Using partition analysis as a facile method to derive net clearances.

机构信息

Department of Pharmaceutical Sciences, Temple University, Philadelphia, Pennsylvania, USA.

出版信息

Clin Transl Sci. 2022 Aug;15(8):1867-1879. doi: 10.1111/cts.13310. Epub 2022 Jun 2.

DOI:10.1111/cts.13310
PMID:35579201
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9372430/
Abstract

Partition analysis has been described previously by W.W. Cleland to derive net rate constants and simplify the derivation of enzyme kinetic equations. Here, we show that partition analysis can be used to derive elimination and transfer (distribution) net clearances for use in pharmacokinetic models. For elimination clearances, the net clearance approach is exemplified with a mammillary two-compartment model with peripheral elimination, and the established well-stirred and full hepatic clearance models. The intrinsic hepatic clearance associated with an observed average hepatic clearance can be easily calculated with net clearances. Expressions for net transfer clearances are easily derived, including models with explicit membranes (e.g., monolayer permeability and blood-brain barrier models). Together, these approaches can be used to derive equations for physiologically based and hybrid compartmental/ physiologically based models. This tutorial describes how net clearances can be used to derive relationships for simple models as well as increasingly complex models, such as inclusion of active transport and target mediated processes.

摘要

分区分析之前由 W.W.克利兰描述得出净速率常数和简化酶动力学方程的推导。在这里,我们表明分区分析可用于推导消除和转移(分布)净清除率,用于药代动力学模型。对于消除清除率,净清除率方法的例子是一个具有外周消除的乳突两室模型,以及建立的良好搅拌和完全肝清除率模型。与观察到的平均肝清除率相关的内在肝清除率可以很容易地用净清除率计算。净转移清除率的表达式很容易推导出来,包括具有明确膜的模型(例如,单层通透性和血脑屏障模型)。这些方法可用于推导基于生理的和混合隔室/基于生理的模型的方程。本教程描述了如何使用净清除率来推导出简单模型以及越来越复杂模型的关系,例如包括主动转运和靶向介导过程。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1894/9372430/c73595431e31/CTS-15-1867-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1894/9372430/de38173d578c/CTS-15-1867-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1894/9372430/44b3bd3f7f30/CTS-15-1867-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1894/9372430/d2a06726eea0/CTS-15-1867-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1894/9372430/f771486d8d5c/CTS-15-1867-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1894/9372430/1caa2c4806ee/CTS-15-1867-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1894/9372430/37a885f1367a/CTS-15-1867-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1894/9372430/e316fc0b6d93/CTS-15-1867-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1894/9372430/c73595431e31/CTS-15-1867-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1894/9372430/de38173d578c/CTS-15-1867-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1894/9372430/44b3bd3f7f30/CTS-15-1867-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1894/9372430/d2a06726eea0/CTS-15-1867-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1894/9372430/f771486d8d5c/CTS-15-1867-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1894/9372430/1caa2c4806ee/CTS-15-1867-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1894/9372430/37a885f1367a/CTS-15-1867-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1894/9372430/e316fc0b6d93/CTS-15-1867-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1894/9372430/c73595431e31/CTS-15-1867-g007.jpg

相似文献

1
Using partition analysis as a facile method to derive net clearances.使用分区分析作为一种简单的方法来推导净清除率。
Clin Transl Sci. 2022 Aug;15(8):1867-1879. doi: 10.1111/cts.13310. Epub 2022 Jun 2.
2
Process and System Clearances in Pharmacokinetic Models: Our Basic Clearance Concepts Are Correct.药代动力学模型中的过程和系统清除率:我们的基本清除率概念是正确的。
Drug Metab Dispos. 2023 Apr;51(4):532-542. doi: 10.1124/dmd.122.001060. Epub 2023 Jan 9.
3
Utility of Minimal Physiologically Based Pharmacokinetic Models for Assessing Fractional Distribution, Oral Absorption, and Series-Compartment Models of Hepatic Clearance.最小生理基于药代动力学模型在评估分数分布、口服吸收和肝脏清除的串联房室模型中的应用。
Drug Metab Dispos. 2023 Oct;51(10):1403-1418. doi: 10.1124/dmd.123.001403. Epub 2023 Jul 17.
4
A Complete Extension of Classical Hepatic Clearance Models Using Fractional Distribution Parameter f in Physiologically Based Pharmacokinetics.使用生理药代动力学中的分数分布参数 f 对经典肝脏清除模型进行全面扩展。
J Pharm Sci. 2024 Jan;113(1):95-117. doi: 10.1016/j.xphs.2023.05.019. Epub 2023 Jun 4.
5
Effect of diffusional barriers on drug and metabolite kinetics.扩散屏障对药物和代谢物动力学的影响。
Drug Metab Dispos. 1987 Jan-Feb;15(1):51-8.
6
A new model-independent physiological approach to study hepatic drug clearance and its applications.一种用于研究肝脏药物清除率的新型非模型依赖生理学方法及其应用。
Int J Clin Pharmacol Ther Toxicol. 1984 Nov;22(11):577-90.
7
Mechanistic modeling of hepatic transport from cells to whole body: application to napsagatran and fexofenadine.从细胞到整体的肝转运的机制建模:在那拉曲坦和非索非那定中的应用。
Mol Pharm. 2009 Nov-Dec;6(6):1716-33. doi: 10.1021/mp8002495.
8
Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption.有机阴离子转运多肽(OATPs)在药物处置中的临床意义:它们在肝脏清除和肠道吸收中的作用。
Biopharm Drug Dispos. 2013 Jan;34(1):45-78. doi: 10.1002/bdd.1823.
9
Applications of minimal physiologically-based pharmacokinetic models.最小生理药代动力学模型的应用。
J Pharmacokinet Pharmacodyn. 2012 Dec;39(6):711-23. doi: 10.1007/s10928-012-9280-2. Epub 2012 Nov 23.
10
Advancing Estimation of Hepatobiliary Clearances in Physiologically Based Pharmacokinetic Models of Rosuvastatin Using Human Hepatic Concentrations.利用人肝浓度推进瑞舒伐他汀基于生理药代动力学模型的肝胆清除率估计
Pharm Res. 2021 Dec;38(12):2035-2046. doi: 10.1007/s11095-021-03138-1. Epub 2021 Dec 3.

引用本文的文献

1
Predicting Clearance with Simple and Permeability-Limited Physiologically Based Pharmacokinetic Frameworks: Comparison of Well-Stirred, Dispersion, and Parallel-Tube Liver Models.运用简单且具有通透性限制的生理药代动力学框架预测清除率:搅拌池、弥散和并行管肝脏模型的比较。
Drug Metab Dispos. 2024 Sep 16;52(10):1060-1072. doi: 10.1124/dmd.124.001782.
2
A Continuous Intestinal Absorption Model to Predict Drug Enterohepatic Recirculation in Healthy Humans: Nalbuphine as a Model Substrate.一种用于预测健康人体中药物肠肝再循环的连续肠道吸收模型:纳布啡作为模型底物。
Mol Pharm. 2024 Sep 2;21(9):4510-4523. doi: 10.1021/acs.molpharmaceut.4c00424. Epub 2024 Jul 2.
3

本文引用的文献

1
Time-dependent enzyme inactivation: Numerical analyses of in vitro data and prediction of drug-drug interactions.时间依赖性酶失活:体外数据的数值分析及药物相互作用的预测。
Pharmacol Ther. 2020 Feb;206:107449. doi: 10.1016/j.pharmthera.2019.107449. Epub 2019 Dec 11.
2
A hybrid model to evaluate the impact of active uptake transport on hepatic distribution of atorvastatin in rats.一种用于评估主动摄取转运对大鼠阿托伐他汀肝脏分布影响的混合模型。
Xenobiotica. 2020 May;50(5):536-544. doi: 10.1080/00498254.2019.1668982. Epub 2019 Oct 1.
3
Prediction of Tissue-Plasma Partition Coefficients Using Microsomal Partitioning: Incorporation into Physiologically based Pharmacokinetic Models and Steady-State Volume of Distribution Predictions.
Process and System Clearances in Pharmacokinetic Models: Our Basic Clearance Concepts Are Correct.
药代动力学模型中的过程和系统清除率:我们的基本清除率概念是正确的。
Drug Metab Dispos. 2023 Apr;51(4):532-542. doi: 10.1124/dmd.122.001060. Epub 2023 Jan 9.
利用微粒体分配预测组织-血浆分配系数:纳入基于生理的药代动力学模型和稳态分布容积预测。
Drug Metab Dispos. 2019 Oct;47(10):1050-1060. doi: 10.1124/dmd.119.087973. Epub 2019 Jul 19.
4
Impact of Lipid Partitioning on the Design, Analysis, and Interpretation of Microsomal Time-Dependent Inactivation.脂质分配对微粒体时间依赖性失活的设计、分析和解释的影响。
Drug Metab Dispos. 2019 Jul;47(7):732-742. doi: 10.1124/dmd.118.085969. Epub 2019 May 1.
5
Improved Predictions of Drug-Drug Interactions Mediated by Time-Dependent Inhibition of CYP3A.时间依赖性抑制 CYP3A 介导的药物相互作用的预测能力得到改善。
Mol Pharm. 2018 May 7;15(5):1979-1995. doi: 10.1021/acs.molpharmaceut.8b00129. Epub 2018 Apr 10.
6
Physiologically Based Pharmacokinetic Modeling of Bosentan Identifies the Saturable Hepatic Uptake As a Major Contributor to Its Nonlinear Pharmacokinetics.基于生理学的波生坦药代动力学模型确定了其饱和性肝摄取为其非线性药代动力学的主要贡献者。
Drug Metab Dispos. 2018 May;46(5):740-748. doi: 10.1124/dmd.117.078972. Epub 2018 Feb 23.
7
Drug Distribution Part 2. Predicting Volume of Distribution from Plasma Protein Binding and Membrane Partitioning.药物分布 第2部分:根据血浆蛋白结合和膜分配预测分布容积
Pharm Res. 2017 Mar;34(3):544-551. doi: 10.1007/s11095-016-2086-y. Epub 2016 Dec 13.
8
Intracellular Unbound Atorvastatin Concentrations in the Presence of Metabolism and Transport.存在代谢和转运情况下细胞内未结合的阿托伐他汀浓度
J Pharmacol Exp Ther. 2016 Oct;359(1):26-36. doi: 10.1124/jpet.116.235689. Epub 2016 Jul 22.
9
Mechanism-Based Inhibition of CYP3A4 by Podophyllotoxin: Aging of an Intermediate Is Important for in Vitro/in Vivo Correlations.鬼臼毒素基于机制的CYP3A4抑制作用:中间体的老化对体外/体内相关性很重要。
Mol Pharm. 2016 Aug 1;13(8):2833-43. doi: 10.1021/acs.molpharmaceut.6b00436. Epub 2016 Jul 1.
10
A physiologically based pharmacokinetic model to predict the pharmacokinetics of highly protein-bound drugs and the impact of errors in plasma protein binding.一种基于生理学的药代动力学模型,用于预测高蛋白结合药物的药代动力学以及血浆蛋白结合误差的影响。
Biopharm Drug Dispos. 2016 Apr;37(3):123-41. doi: 10.1002/bdd.1996.